61 related articles for article (PubMed ID: 15365956)
1. Modulation of osteoblast activity by serum from diabetic and non-diabetic patients on hemodialysis: a three-dimensional culture study.
Serrano S; Mariñoso ML; Nacher M; Torres A; Cuevas X; Loreta J; Munné A; Diez A
J Nephrol; 2004; 17(3):369-76. PubMed ID: 15365956
[TBL] [Abstract][Full Text] [Related]
2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
[TBL] [Abstract][Full Text] [Related]
4. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
6. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
Takahashi N; Kojima T; Ogawa H; Ishiguro N
Nephrology (Carlton); 2007 Dec; 12(6):539-45. PubMed ID: 17995578
[TBL] [Abstract][Full Text] [Related]
7. Increased serum osteoprotegerin level in older and diabetic hemodialysis patients.
Doi S; Yorioka N; Masaki T; Ito T; Shigemoto K; Harada S
Ther Apher Dial; 2004 Aug; 8(4):335-9. PubMed ID: 15274686
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
Pabico RC; Rivero AJ; McKenna BA; Freeman RB
Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
[TBL] [Abstract][Full Text] [Related]
9. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of patients on hemodialysis therapy for more than 30 years.
Otsubo S; Otsubo K; Sugimoto H; Ueda S; Otsubo Y; Otsubo O; Yajima A; Yagi S; Kataoka H; Iwasaki T; Iwasa Y; Takahashi M; Aoki A; Ino J; Uchida K; Yumura W; Akiba T; Nitta K
Ther Apher Dial; 2007 Aug; 11(4):274-9. PubMed ID: 17661833
[TBL] [Abstract][Full Text] [Related]
11. [Bone abnormalities in diabetic hemodialysis patients].
Okuno S; Inaba M
Clin Calcium; 2006 Aug; 16(8):1344-50. PubMed ID: 16883043
[TBL] [Abstract][Full Text] [Related]
12. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
[TBL] [Abstract][Full Text] [Related]
13. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
14. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years].
Van Landeghem MA
Med Klin (Munich); 2005 May; 100(5):241-5. PubMed ID: 15902377
[TBL] [Abstract][Full Text] [Related]
15. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.
Murakami R; Murakami S; Tsushima R; Ueda C; Mikami K; Ebina T; Kumasaka R; Nakamura N; Okumura K
Nephrol Dial Transplant; 2008 Jan; 23(1):315-20. PubMed ID: 17956892
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females.
Abdallah BM; Haack-Sørensen M; Fink T; Kassem M
Bone; 2006 Jul; 39(1):181-8. PubMed ID: 16530029
[TBL] [Abstract][Full Text] [Related]
18. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
Bradran A; Nasri H
J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
[TBL] [Abstract][Full Text] [Related]
19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
20. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
